Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
Submitted by
admin
on May 21, 2015 - 8:47am
Source:
BioPharma Dive
News Tags:
Amgen
PCSK9 inhibitor
Repatha
Europe
Sanofi
Regeneron
Praluent
Headline:
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
Do Not Allow Advertisers to Use My Personal information
